Shanghai, China

Guoli Zhang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Guoli Zhang: Innovator in Pharmaceutical Compounds

Introduction

Guoli Zhang is a prominent inventor based in Shanghai, China, known for his contributions to the field of pharmaceuticals. With a total of three patents to his name, Zhang has made significant strides in developing innovative compounds that address various medical conditions.

Latest Patents

One of Zhang's latest patents is a fused tri-cyclic compound that acts as a PDE3/PDE4 dual inhibitor. This compound is particularly useful in the preparation of drugs for diseases associated with PDE3/PDE4, including chronic obstructive pulmonary disease (COPD). The patent specifically details a compound of formula (I) and its pharmaceutically acceptable salts. Another notable patent involves a bicyclic compound that serves as a CRBN protein regulator. This compound, represented by formula (III), is also accompanied by its pharmaceutically acceptable salts and is intended for use in medications targeting diseases related to the CRBN receptor.

Career Highlights

Throughout his career, Guoli Zhang has worked with several reputable companies, including Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work in these organizations has allowed him to focus on the development of innovative pharmaceutical solutions.

Collaborations

Zhang has collaborated with notable colleagues such as Yunfu Luo and Shuhui Chen, contributing to the advancement of research and development in the pharmaceutical industry.

Conclusion

Guoli Zhang's innovative work in developing pharmaceutical compounds highlights his significant impact on medical science. His patents reflect a commitment to addressing critical health issues through research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…